Архивъ внутренней медицины

Расширенный поиск


Полный текст:


Железодефицит является одной из коморбидностей у больных ожирением, что позволяет выделять особый фенотип («железодефицитный») ожирения. Имеются убедительные доказательства патогенетической связи между железодефицитом и наличием системного воспаления, ассоциированного с ожирением. Данные о частоте и патогенетическом варианте анемии (железодефицитная или анемия хронических заболеваний) при ожирении неоднозначны. Необходимы дальнейшие исследования ферростатуса у больных с ожирением для решения вопроса о целесообразности и способах коррекции нарушений метаболизма железа, в частности при подготовке пациентов к бариатрическим операциям.

Об авторах

Л. И. Дворецкий
ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

О. В. Ивлева
ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

Список литературы

1. Finucane M. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377: 557-567.

2. World Health Organization (WHO), available at:

3. World Health Organization (WHO), Fact Sheet No.311 (May 2012) available at:

4. Frühbeck G., Toplak H., Woodward E. et al. Obesity: The gateway to ill health — an EASO Position Statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013; 6: 117-120.

5. WHO: The world health report 2002 — Reducing Risks, Promoting Healthy Life.

6. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005.

7. Mendez M.A., Monteiro C.A., Popkin B.M. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr. 2005; 81: 714–721

8. Lee J., Houser R.F., Must A. et al. Socioeconomic disparities and the familial coexistence of child stunting and maternal overweight in Guatemala. Econ Hum Biol. 2012; 10: 232–241.

9. Doak C.M., Adair L.S., Monteiro C., Popkin B.M. Overweight and underweight coexist within households in Brazil, China and Russia. J Nutr. 2000; 130: 2965–2971.

10. Wenzel B.J., Stults H.B., Mayer J. Hypoferraemia in obese adolescents. Lancet. 1962; 280: 327–328

11. Seltzer C.C., Mayer J. Serum Iron and Iron-Binding Capacity in Adolescents. II. Comparison of Obese and Nonobese Subjects. Am J Clin Nutr. 1963; 13 (6): 354-361.

12. Pinhas-Hamiel O., Newfield R.S., Koren I. et al. Greater prevalence of iron defiency in overweiht and obese children and adolescents. Int J Obes Relat Metab. Disord. 2003; 27: 416-418.

13. Nead K.G., Halterman J.S., Kaczorowski J.M. et al. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004; 114: 104-108.

14. Tussing-Humphreys L.M., Liang H., Nemeth E. et al. Excess adiposity, inflammation, and iron-deficiency in female adolescents. J. Am. Diet. Assoc. 2009; 109: 297–302.

15. Sanad M., Osman M., Gharib A. Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study. Ital. J. Pediatr. 2011; 37: 34.

16. Lecube A., Carrera A., Losada E. et al. Iron deficiency in obese postmenopausal women. Obesity. 2006; 14: 1724-1730.

17. O’Broin B., Kelleher B., Balfe A., McMahon C. Evaluation of serum transferring receptor assay in a centralized iron screening service. Clin Lab Haem. 2005; 27: 190-194.

18. Wish B. Assessing iron status: beyond sеrum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006; l (Suppl): 54-58.

19. Yanoff L.B., Menzie C.M., Denkinger B. et at Innammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond). 2007; 31: 1412-1419.

20. Mеnzie C.M., Yanoff L.B., Oenkinger B.I. еt al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc. 2008; 108: 145-148.

21. Karl J.P., Lieberman H.R., Cable S.J. et al. Poor iron status is not associated with overweight or overfat in non-obese pre-menopausal women. J Am Coll Nutr. 2009; 28: 37–42.

22. Fanou-Fogny N., Saronga N.J., Koreissi Y. et al. Weight status and iron deficiency among urban Malian women of reproductive age. Br J Nutr. 2011; 105: 574–579.

23. Eckhardt C.L., Torheim L.E., Monterrubio E. et al. The overlap of overweight and anaemia among women in three countries undergoing the nutrition transition. Eur J Clin Nutr. 2008; 62: 238–46.

24. Datz C., Felder T.K., Niederseer D., Aigner E. Iron homeostasis in the metabolic syndrome. Eur. J. Clin. Investig. 2013; 43: 215–224.

25. Nikonorova A.A., Skalnayab M.G., Tinkova A. et al. Mutual interaction between iron homeostasis and obesity pathogenesis. Journal of Trace Elements in Medicine and Biology. 2015; 30: 207–214.

26. Hassapidou M., Fotiadou E., Maglara E. et al. Energy intake: diet composition, energy expenditure, and body fatness of adolescents in northern Greece. Obesity 2006; 14 (5): 855–862.

27. Newman B.H. Vasovagal reaction rates and body weight: findings in high- and low-risk populations. Transfusion. 2003; 43: 1084–1088.

28. Bertinato J., Aroche C., Plouffe L.J. et al. Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency. Eur J Nutr. 2013; 53 (3): 885–889.

29. Zimmermann M.B., Zeder С., Muthayya S. et al. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int. J. Obes. 2008; 32: 1098–1104.

30. Mujica-Coopmana M. F., Britoa A., López de Romañaa D. et al. Body mass index, iron absorption and iron status in childbearing age women. Journal of Trace Elements in Medicine and Biology 2015; 30: 215–219.

31. Yanoff L.B., Menzie C.M., Denkinger B. et at Innammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond). 2007; 31: 1412-1419.

32. Day C.P. From fat to inflammation. Gastroenterology 2006; 130: 207–210.

33. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005; 184: 285–293.

34. Trayhurn P., Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005; 33: 1078–1081.

35. Greenberg A.S., Obin M.S.. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006; 83: 461S–465S.

36. Weisberg S.P., McCann D., Desai M. et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796–1808.

37. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19: 972–978.

38. Mohamed-Ali V., Goodrick S., Rawesh A. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997; 82: 4196–4200.

39. Tzanavari T., Giannogonas P., Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010; 11: 145−56

40. Alessi MC, Bastelica D, Morange P et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000; 49: 1374–1380.

41. Lopez A.C., Osendarp S.J.M., Boonstra A.M. et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr May. 2011; 93(5): 975-983.

42. Bekri S., Gual P., Anty R. et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006; 131: 788–796.

43. Nemeth E.R., Rivera S., Gabayan V. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113: 1271–1276.

44. del Giudice E.M., Santoro N., Amato A. et al. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J. Clin. Endocrinol. Metab. 2009; 94: 5102–5107.

45. Aeberli I., Hurrell R.F., Zimmermann M.B. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int. J. Obes. 2009; 33: 1111–1117.

46. Tussing-Humphreys L., Frayn K.N., Smith S.R. et al. Subcutaneous adipose tissue from obese and lean adults does not release hepcidin in vivo. Sci. World J. 2011; 11: 2197–2206.

47. Ganz T., Nemeth E. Iron sequestration and anemia of inflammation. Semin. Hematol. 2009; 46: 387–393.

48. Tussing-Humphreys L.M., Nemeth E., Fantuzzi G. et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity (Silver Spring). 2010; 18: 2010–2016.

49. Sonnweber T., Ress C., Nairz M. et al. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J. Nutr. Biochem. 2012; 23: 1600–1608.

50. Aigner E., Theurl I., Haufe H. et al. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology. 2008; 135: 680–688.

51. Dongiovanni P., Fracanzani A.L., Fargion S., Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J. Hepatol. 2011; 55: 920–932.

52. Aigner E., Theurl I., Theurl M. et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 2008; 87: 1374–1383.

53. Barisani D., Pelucchi S., Mariani R. et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J. Hepatol. 2008; 49: 123–133.

54. Ruivard M., Laine F., Ganz T. et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J. Hepatol. 2009; 50: 1219–1225.

55. Ruivard M., Laine F., Ganz T. et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J. Hepatol. 2009; 50: 1219–1225.

56. Aigner E., Feldman A., Datz C. Obesity as an Emerging Risk Factor for Iron Deficiency. Nutrients. 2014; 6(9): 3587-3600.

57. Ausk K.J., Ioannou G.N. Is obesity associated with anemia of chronic disease? A population-based study. Obesity (Silver Spring). 2008; 16: 2356–2361.

58. Kordas K., Centeno Y. Z., Pachón H. et al. Being Overweight or Obese Is Associated with Lower Prevalence of Anemia among Colombian Women of Reproductive Age. J. Nutr. 2013; 143(2): 175-181.

59. Eftekhari M., Mozaffari-Khosravi H., Shidfar F. The relationship between BMI and iron status in iron-deficient adolescent Iranian girls. Public Health Nutr. 2009; 12: 2377–2381.

60. Cheng H.L., Bryant C., Cook R. et al. The relationship between obesity and hypoferraemia in adults: A systematic review. Obes. Rev. 2012; 13: 150–161.

61. Wessling-Resnick М. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010; 30: 105-122.

62. Tussing-Humphreys L., Pustacioglu C., Nemeth E., Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. Jour of Acad of Nutr and Diet. 2012; 112: 391–400.

63. Nairz M., Haschka D., Demetz E., Weiss G. Iron at the interface of immunity and infection. Front Pharmacol. 2014;5: 152.

64. Munoz M., Botella-Romero F., Gomez-Ramirez S. et al. Iron deficiency and anaemia in bariatric surgical patients: Causes, diagnosis and proper management. Nutr. Hosp. 2009; 24: 640–654.

65. Manios Y., Moschonis G., Chrousos G.P. et al. The double burden of obesity and iron deficiency on children and adolescents in greece: The healthy growth study. J. Hum. Nutr. Diet. 2013; 26: 470–478.

66. Aktas G., Alcelik A., Yalcin A. et al. Treatment of iron deficiency anemia induces weight loss and improves metabolic parameters. Clin. Ter. 2014; 165: e87–e89.

67. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. J. Parenter. Enteral Nutr. 1988; 12: 282–285.

68. Hallet J., Hanif A., Callum J. et al. The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: A systematic review and meta-analysis. Transfus Med Rev. 2014 Oct;28(4):205-211.

69. Shander A., Van Aken H., Colomina M.J. et al. Patient blood management in europe. Br. J. Anaesth. 2012; 109: 55–68.

70. Flancbaum L., Belsley S., Drake V. et al. Preoperative nutritional status of patients undergoing roux-en-y gastric bypass for morbid obesity. J. Gastrointest. Surg. 2006; 10: 1033–1037.

71. Damms-Machado A., Friedrich A., Kramer K.M. et al. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes. Surg. 2012; 22: 881–889.

72. Ernst B., Thurnheer M., Schmid S.M. et al. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes. Surg. 2009; 19: 66–73.

73. Marambio A., Watkins G., Castro F. et al. Changes in iron transporter divalent metal transporter 1 in proximal jejunum after gastric bypass. World J. Gastroenterol. 2014; 20: 6534–6540.

74. Ruz M., Carrasco F., Rojas P. et al. Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and roux-en-y gastric bypass in morbidly obese women. Am. J. Clin. Nutr. 2012; 96: 810–817.

75. Дворецкий Л.И., Юшков Ю.И., Ивлева О.В. и др. Анемический синдром у больных после билиопанкреатического шунтирования. Российские медицинские вести. 2014; 4: 48-57.

Для цитирования:

Дворецкий Л.И., Ивлева О.В. ОЖИРЕНИЕ И ЖЕЛЕЗОДЕФИЦИТ. ЕЩЕ ОДНА КОМОРБИДНОСТЬ? Архивъ внутренней медицины. 2015;(5):9-16.

For citation:

L.I. Dvoretsky L.I., Ivleva . BESITY AND IRON DEFICIENCY. ONE MORE COMORBIDITY? The Russian Archives of Internal Medicine. 2015;(5):9-16. (In Russ.)

Просмотров: 240

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)